As of 2025-07-15, the Fair Value of Marinus Pharmaceuticals Inc (MRNS) is -12.72 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.55 USD, the upside of Marinus Pharmaceuticals Inc is -2,412.91%.
With the market price of 0.55 USD and our fair value calculation, Marinus Pharmaceuticals Inc (MRNS) is not a good investment. Investing in MRNS stocks now will result in a potential loss of 2,412.91%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |
| Net income | -54.12 | -67.48 | -98.78 | -19.82 | -141.40 | -76.32 |
| YoY growth | -47.35% | -24.69% | -46.38% | 79.94% | -613.45% | -130.39% |
| Market Cap (mil) | 30.37 |
| P/E | |
| Forward P/E |
| EPS | -2.54 |
| Avg earnings growth rate | -130.39% |
| TTM earnings | -140.49 |